Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present CRYO-CELL International, Inc. (OTC: CCEL).

Full DD Report for CCEL

You must become a subscriber to view this report.


Recent News from (OTC: CCEL)

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2018 Financial Results
OLDSMAR, Fla., April 16, 2018 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2018.&#x...
Source: GlobeNewswire
Date: April, 16 2018 17:14
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2017
OLDSMAR, Fla., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2017. Financia...
Source: GlobeNewswire
Date: February, 28 2018 16:15
CRYO-CELL International reports Q3 results
CRYO-CELL International ( OTCPK:CCEL ): Q3 EPS of $0.08 Revenue of $6.9M (+9.5% Y/Y) Press Release More news on: CRYO-CELL International, Inc., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: October, 16 2017 16:27
Cryo-Cell Reports Fiscal Third Quarter 2017 Results
OLDSMAR, Fla., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2017. F...
Source: GlobeNewswire
Date: October, 16 2017 16:15
CRYO-CELL International reports Q2 results
CRYO-CELL International ( OTCPK:CCEL ): Q2 EPS of $0.06 Revenue of $6.2M (+6.9% Y/Y) Press Release More news on: CRYO-CELL International, Inc., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: July, 07 2017 16:32
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2017 Financial Results
OLDSMAR, Fla., July 07, 2017 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2017.  ...
Source: GlobeNewswire
Date: July, 07 2017 16:30
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2017 Financial Results
OLDSMAR, Fla., April 14, 2017 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2017. &#...
Source: GlobeNewswire
Date: April, 14 2017 16:00
CRYO-CELL International reports FY results
CRYO-CELL International ( OTCPK:CCEL ): FY EPS of -$0.16 Revenue of $23.1M (+9.5% Y/Y) Press Release More news on: CRYO-CELL International, Inc., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: February, 28 2017 17:57
Cryo-Cell Reports Financial Results for Fiscal 2016
OLDSMAR, Fla., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year 2016.   Financial Results ...
Source: GlobeNewswire
Date: February, 28 2017 17:53
CRYO-CELL International reports FQ3 results
CRYO-CELL International ( OTCPK:CCEL ): FQ3 EPS of -$0.35 Revenue of $6.3M (+16.7% Y/Y) Press Release More news on: CRYO-CELL International, Inc., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: October, 18 2016 17:05

 


About CRYO-CELL International, Inc. (OTC: CCEL)

Logo for CRYO-CELL International, Inc. (OTC: CCEL)

Based in Oldsmar, Florida, with over , clients worldwide, Cryo Cell is one of the largest and most established family cord blood banks. ISO : certified and accredited by the AABB, Cryo Cell operates in a state of the art Good Manufacturing Practice and Good Tissue Practice cGMP/cGTP compliant facility. The Menstrual Stem Cell service was introduced in November as the first and only service that empowers women to collect and cryopreserve menstrual flow containing undifferentiated adult stem cells for future utilization by the donor or possibly their first degree relatives in a manner similar to umbilical cord blood stem cells. For more information, visit www.celle.com. OTCQB Symbol: CCEL. Expectant parents or healthcare professionals may call STOR CELL or visit www.cryo cell.com.

 

Contact Information

 

 

Current Management

  • David I. Portnoy / CoCEO
  • Mark L. Portnoy / CoCEO
  • Jill M. Taymans / VP, Fin., IR
  • David I. Portnoy / Chairman
  • Anthony Atala /
  • Harold D. Berger /
  • George Gaines / Director
    • George Gaines has worked as a marketing sciences professional for over years. He completed his doctorate at the University of Georgia in and served as an Associate Professor at The University of New Orleans and Louisiana State University Medical Center until . During his academic career, Dr. Gaines authored and coauthored more than books, journal articles, and papers and training sessions presented at professional organizations. He directed numerous doctoral dissertations and masters theses. For the next years, Dr. Gaines was an officer for some of the world s most prestigious international marketing research organizations, including The Gallup Organization, TNSResearch International, and IpsosSynovate. His wellrounded private sector research included two years at The Southern Company, the largest electric holding company in the US. He also conducted research for numerous technology companies such as Picker International, Sensormatic, and Lufthansa Technik. His last years were spent as Director of Consumer Insights, Outback Steakhouse International. Dr. Gaines has lived in Princeton, NJ, Wiesbaden, Germany Phoenix, New York City, and Atlanta. He and his family currently reside in Tarpon Springs, Florida.
  • Mark L. Portnoy /
  • Jonathan H. Wheeler /

Current Share Structure

  • Market Cap: $100,909,699 - 03/16/2018
  • Authorized: 20,000,000 - 03/12/2018
  • Issue and Outstanding: 13,544,926 - 03/12/2018
  • Float: 10,000,000 - 02/28/2011

 


Recent Filings from (OTC: CCEL)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 18 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 01 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 28 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: February, 15 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 19 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: October, 17 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: October, 17 2017

 

 


Daily Technical Chart for (OTC: CCEL)

Daily Technical Chart for (OTC: CCEL)


Stay tuned for daily updates and more on (OTC: CCEL)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CCEL)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CCEL is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of CCEL and does not buy, sell, or trade any shares of CCEL. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/